Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 149

Similar articles for PubMed (Select 23484688)

1.

[Clinical significance of common leukemia gene mutations in patients with acute promyelocytic leukemia].

Yin J, Sun AN, Tian XP, Tian H, Wang RX, Yang Z, Wang XL, Wu DP, Qiu HY, Pan JL, Cen JN, Liang JY, Chen SN.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Feb;21(1):39-44. doi: 10.7534/j.issn.1009-2137.2013.01.009. Chinese.

PMID:
23484688
2.

[Prevalence and clinical significance of FLT3 mutations in acute promyelocytic leukemia].

Xue MX, Qiu HY, Feng YF, Zhu ZL, Chang WR, Liang JY, Chen SN, Cen JN, Xue YQ, Liu YJ, Sun AN, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2008 Nov;29(11):757-61. Chinese.

PMID:
19176014
3.

[Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].

Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):601-6. doi: 10.7534/j.issn.1009-2137.2013.03.013. Chinese.

PMID:
23815906
4.

[C-kit, NPM1 and FLT3 gene mutation patterns and their prognostic significance in 656 Chinese patients with acute myeloid leukemia].

Ding ZX, Shen HJ, Miao JC, Chen SN, Qiu QC, Qi XF, Jin ZM, Wu DP, He J.

Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):829-34. Chinese.

5.

Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias.

Rocquain J, Carbuccia N, Trouplin V, Raynaud S, Murati A, Nezri M, Tadrist Z, Olschwang S, Vey N, Birnbaum D, Gelsi-Boyer V, Mozziconacci MJ.

BMC Cancer. 2010 Aug 2;10:401. doi: 10.1186/1471-2407-10-401.

6.

TET2 gene mutation is unfavorable prognostic factor in cytogenetically normal acute myeloid leukemia patients with NPM1+ and FLT3-ITD - mutations.

Tian X, Xu Y, Yin J, Tian H, Chen S, Wu D, Sun A.

Int J Hematol. 2014 Jul;100(1):96-104. doi: 10.1007/s12185-014-1595-x. Epub 2014 May 24.

PMID:
24859829
7.

Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group.

Callens C, Chevret S, Cayuela JM, Cassinat B, Raffoux E, de Botton S, Thomas X, Guerci A, Fegueux N, Pigneux A, Stoppa AM, Lamy T, Rigal-Huguet F, Vekhoff A, Meyer-Monard S, Ferrand A, Sanz M, Chomienne C, Fenaux P, Dombret H; European APL Group.

Leukemia. 2005 Jul;19(7):1153-60.

PMID:
15889156
8.

Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.

Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C.

Genes Chromosomes Cancer. 2003 Jul;37(3):237-51.

PMID:
12759922
9.

FLT3 and NPM1 mutations in a cohort of AML patients and detection of a novel mutation in tyrosine kinase domain of FLT3 gene from Western India.

Ghosh K, Swaminathan S, Madkaikar M, Gupta M, Kerketta L, Vundinti B.

Ann Hematol. 2012 Nov;91(11):1703-12. doi: 10.1007/s00277-012-1509-z. Epub 2012 Jun 26.

PMID:
22733614
10.

Internal tandem duplication and Asp835 mutations of the FMS-like tyrosine kinase 3 (FLT3) gene in acute promyelocytic leukemia.

Shih LY, Kuo MC, Liang DC, Huang CF, Lin TL, Wu JH, Wang PN, Dunn P, Lai CL.

Cancer. 2003 Sep 15;98(6):1206-16.

11.

Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).

Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.

Ann Hematol. 2012 Jan;91(1):9-18. doi: 10.1007/s00277-011-1280-6. Epub 2011 Jul 9.

PMID:
21744003
12.

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication.

Paschka P, Schlenk RF, Gaidzik VI, Habdank M, Krönke J, Bullinger L, Späth D, Kayser S, Zucknick M, Götze K, Horst HA, Germing U, Döhner H, Döhner K.

J Clin Oncol. 2010 Aug 1;28(22):3636-43. doi: 10.1200/JCO.2010.28.3762. Epub 2010 Jun 21.

13.

[Analysis of tyrosine kinases gene mutations in core binding factor related acute myeloid leukemia and its clinical significance].

Qiao M, Li WY, Sun AN, Chen SN, Liang JY, Ding ZX, Feng YF, Wu DP.

Zhonghua Xue Ye Xue Za Zhi. 2011 Oct;32(10):679-83. Chinese.

14.

Molecular characteristics and chromatin texture features in acute promyelocytic leukemia.

De Mello MR, Albuquerque DM, Pereira-Cunha FG, Albanez KB, Pagnano KB, Costa FF, Metze K, Lorand-Metze I.

Diagn Pathol. 2012 Jun 28;7:75. doi: 10.1186/1746-1596-7-75.

15.

Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.

Lucena-Araujo AR, Kim HT, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Chauffaille Mde L, Chiattone CS, Lima AS, Ruiz-Argüelles G, Undurraga MS, Martinez L, Kwaan HC, Gallagher R, Niemeyer CM, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM.

Ann Hematol. 2014 Dec;93(12):2001-10. doi: 10.1007/s00277-014-2142-9. Epub 2014 Jul 2.

PMID:
24981688
16.

[FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].

Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009 Oct;17(5):1135-9. Chinese.

PMID:
19840437
17.

Cytogenetic and FMS-like tyrosine kinase 3 mutation analyses in acute promyelocytic leukemia patients.

Yaghmaie M, Alimoghaddam K, Mozdarani H, Ghavamzadeh A, Hajhashemi M, Aznab M, Ghaffari SH.

Iran Biomed J. 2012;16(1):10-7.

18.

FLT3 and NPM1 gene mutations in childhood acute myeloblastic leukemia.

Mukda E, Pintaraks K, Sawangpanich R, Wiangnon S, Pakakasama S.

Asian Pac J Cancer Prev. 2011;12(7):1827-31.

19.

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: a systematic review.

Beitinjaneh A, Jang S, Roukoz H, Majhail NS.

Leuk Res. 2010 Jul;34(7):831-6. doi: 10.1016/j.leukres.2010.01.001. Epub 2010 Jan 21. Review.

PMID:
20096459
20.

Long FLT3 internal tandem duplications and reduced PML-RARα expression at diagnosis characterize a high-risk subgroup of acute promyelocytic leukemia patients.

Chillón MC, Santamaría C, García-Sanz R, Balanzategui A, Sarasquete ME, Alcoceba M, Marín L, Caballero MD, Vidriales MB, Ramos F, Bernal T, Díaz-Mediavilla J, García de Coca A, Peñarrubia MJ, Queizán JA, Giraldo P, San Miguel JF, González M.

Haematologica. 2010 May;95(5):745-51. doi: 10.3324/haematol.2009.015073. Epub 2010 Feb 4.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk